Anaptysbio (ANAB) Common Equity (2016 - 2025)
Historic Common Equity for Anaptysbio (ANAB) over the last 10 years, with Q3 2025 value amounting to -$29.4 million.
- Anaptysbio's Common Equity fell 13486.67% to -$29.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.4 million, marking a year-over-year decrease of 13486.67%. This contributed to the annual value of $70.9 million for FY2024, which is 1956.23% down from last year.
- According to the latest figures from Q3 2025, Anaptysbio's Common Equity is -$29.4 million, which was down 13486.67% from -$44.7 million recorded in Q2 2025.
- In the past 5 years, Anaptysbio's Common Equity registered a high of $385.7 million during Q2 2021, and its lowest value of -$44.7 million during Q2 2025.
- In the last 5 years, Anaptysbio's Common Equity had a median value of $148.4 million in 2023 and averaged $179.1 million.
- As far as peak fluctuations go, Anaptysbio's Common Equity surged by 648.59% in 2021, and later plummeted by 55280.9% in 2025.
- Over the past 5 years, Anaptysbio's Common Equity (Quarter) stood at $356.4 million in 2021, then dropped by 26.46% to $262.1 million in 2022, then plummeted by 66.39% to $88.1 million in 2023, then fell by 19.56% to $70.9 million in 2024, then plummeted by 141.51% to -$29.4 million in 2025.
- Its last three reported values are -$29.4 million in Q3 2025, -$44.7 million for Q2 2025, and $34.0 million during Q1 2025.